Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Closes Lifecodes Acquisition

NEW YORK, Dec. 6 — Orchid BioSciences announced on Thursday that it had completed the acquisition of  Lifecodes, which specializes in genomics testing for forensics and paternity applications, giving Orchid a significant boost in identity testing and forensic genomics.

 

The acquisition, first announced on Oct. 1, is valued at $12.6 million and is structured as a tax-free stock-for-stock transaction under which Lifecodes shareholders will receive an aggregate of 6.6 million new shares of Orchid common stock.

 

Lifecodes recently began marketing a new HLA typing system. Orchid plans to fold this innovation and other products and services into its new Orchid Diagnostics unit, which will market these services alongside its own genetic diagnostic for cystic fibrosis. The company said the division will have sales of more than $12 million in 2002.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.